By modulating fatty acid metabolism in lung cancer via the CPT1A-mediated FAO pathway, miR-365-3p plays a critical role in inhibiting the proliferation and migration of cancer cells, both in vivo and in vitro. Here, CPT1A is linked to lung carcinoma.